Fig. 2

Potential therapeutic intervention based on genomic alterations. Therapeutics targeting of a cell cycle and b RTK/RAS/PI(3)K signaling associated elements. Percentages are based on the The Cancer Genome Atlas Network report [19]. RTK = receptor tyrosine kinase